Cited by 135Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes

Open access
Adams, Deanna G., Coffee, R. Lane, Zhang, Hong, Pelech, Steven, Strack, Stefan, Wadzinski, Brian E.·2005·Journal of Biological Chemistry

Abstract

Protein serine/threonine phosphatase 2A (PP2A) regulates a wide variety of cellular signal transduction pathways. The predominant form of PP2A in cells is a heterotrimeric holoenzyme consisting of a scaffolding (A) subunit, a regulatory (B) subunit, and a catalytic (C) subunit. Although PP2A is known to regulate Raf1-MEK1/2-ERK1/2 signaling at multiple steps in this pathway, the specific PP2A holoenzymes involved remain unclear. To address this question, we established tetracycline-inducible human embryonic kidney 293 cell lines for overexpression of FLAG-tagged Balpha/delta regulatory subunits by approximately 3-fold or knock-down of Balpha by greater than 70% compared with endogenous levels. The expression of functional epitope-tagged B subunits was confirmed by the detection of A and C subunits as well as phosphatase activity in FLAG immune complexes from extracts of cells overexpressing the FLAG-Balpha/delta subunit. Western analysis of the cell extracts using phosphospecific antibodies for MEK1/2 and ERK1/2 demonstrated that activation of these kinases in response to epidermal growth factor was markedly diminished in Balpha knock-down cells but elevated in Balpha- and Bdelta-overexpressing cells as compared with control cells. In parallel with the activation of MEK1/2 and ERK1/2, the inhibitory phosphorylation site of Raf1 (Ser-259) was dephosphorylated in cells overexpressing Balpha or Bdelta. Pharmacological inhibitor studies as well as reporter assays for ERK-dependent activation of the transcription factor Elk1 revealed that the PP2A holoenzymes ABalphaC and ABdeltaC act downstream of Ras and upstream of MEK1 to promote activation of this MAPK signaling cascade. Furthermore both PP2A holoenzymes were found to associate with Raf1 and catalyze dephosphorylation of inhibitory phospho-Ser-259. Together these findings indicate that PP2A ABalphaC and ABdeltaC holoenzymes function as positive regulators of Raf1-MEK1/2-ERK1/2 signaling by targeting Raf1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m502464200

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Loss- and gain-of-function experiments in serum-starved HEK cells supported a role for PP2A/B55 trimers in MEK1/2 and ERK1/2 activation through RAF1.

    “Loss and gain of B55α and B55δ function in serum-starved HEK cells re-stimulated with EGF confirmed the implication of PP2A/B55 trimeric holoenzymes in MEK1/2 and ERK1/2 activation via RAF1 activation (Adams et al., 2005).”
  • PP2A/B55α and B55δ dephosphorylate RAF1 at Ser259.

    “In the MAPK pathway, PP2A/B family members B55α and B55δ dephosphorylate RAF1 on Ser259 (Adams et al., 2005; Ory et al., 2003), a residue that when phosphorylated inhibits RAF1 kinase by binding to 14-3-3 proteins (Abraham et al., 2000; Jaumot and Hancock, 2001).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Silverstein, A. M., Barrow, C. A., Davis, A. J., and Mumby, M. C. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 4221-4226
  2. Peterson, R. T., Desai, B. N., Hardwick, J. S., and Schreiber, S. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4438 -4442
  3. Pelech, S., Sutter, C., and Zhang, H. (2003) in Methods in Molecular Medicine Series (Terrian, D., ed) Vol. 218, pp. 99 -111, Humana Press, Totowa, NJ 47.

Cited by

Sorted by citations

Authors
Adams, D. G., Coffee, R. L., Zhang, H., Pelech, S., Strack, S., & Wadzinski, B. E.
Affiliations
  • Vanderbilt University Medical Center (US)
  • Kinexus Bioinformatics Corporation (Canada) (CA)
  • University of British Columbia (CA)
  • University of Iowa (US)
Corresponding author
Wadzinski, Brian E.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-12
Volume
280
Issue
52
Pages
42644-42654
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2055476265
Cited by
133
References
55
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 10 · 2012: 9
FWCI
4.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Vanderbilt University (DK20593, CA68485)
  • Vanderbilt-Ingram Cancer Center (CA68485)
  • National Institutes of Health (CA68485, DK 20593)
  • Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
  • National Institute of Mental Health (MH19732, T32MH019732)
  • National Cancer Institute (CA68485, P30CA068485)
  • National Institute of General Medical Sciences (R01GM062265, GM-51366, GM62265)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 20593, T32DK007563)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
Raf-1, MEK1/2, ERK1/2, MAPK signaling, PP2A holoenzyme, epidermal growth factor, Ras
MeSH terms
Epitopes, Cell Line, Enzyme Activation, Enzyme Inhibitors, Humans, Luciferases, Phosphoprotein Phosphatases, Phosphorylation, Plasmids, Serine, Tetracycline, Transfection, Immunoblotting, Blotting, Western, Signal Transduction, Gene Expression Regulation, Enzymologic, Dimerization, Proto-Oncogene Proteins c-raf, Mitogen-Activated Protein Kinase 1, Reverse Transcriptase Polymerase Chain Reaction, Catalytic Domain, MAP Kinase Signaling System, RNA Interference, Immunoprecipitation, Mitogen-Activated Protein Kinase 3, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review